SPOTLIGHT -
ASCO 2016: Phase I Trial Results With Vorinostat in Head and Neck Cancer
In this interview, Theodoros Teknos, MD, discusses the results of his current phase I trial of vorinostat (Zolinza) in advanced head and neck cancer.